Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Prepaid Assets (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Prepaid Assets for 4 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 18.55% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2025, down 18.55% year-over-year, with the annual reading at $10.9 million for FY2025, 18.55% down from the prior year.
  • Prepaid Assets for Q4 2025 was $10.9 million at Day One Biopharmaceuticals, up from $1.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $13.4 million in Q4 2024, with the low at $305000.0 in Q1 2025.
  • Average Prepaid Assets over 4 years is $4.7 million, with a median of $3.1 million recorded in 2022.
  • The sharpest move saw Prepaid Assets surged 957.54% in 2023, then crashed 90.88% in 2024.
  • Over 4 years, Prepaid Assets stood at $5.6 million in 2022, then skyrocketed by 59.27% to $8.9 million in 2023, then surged by 50.25% to $13.4 million in 2024, then decreased by 18.55% to $10.9 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $10.9 million, $1.3 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.